Save Money / Consumer News
Counterfeit Botox may have shipped to California doctors
LOS ANGELES (KABC) -- The U.S. Food and Drug Administration is warning doctors that they may have received unapproved versions of Botox.
Federal regulators say a Canadian supplier shipped out versions of the popular wrinkle treatment that's unapproved by the FDA and possibly counterfeit. The agency said it cannot assure the products' effectiveness or safety.
The FDA says the supplier, Canada Drugs, has shipped out fake cancer drugs in the past. The company also operates under the following names: Quality Specialty Products (QSP), A+ Health Supplies, QP Medical, Bridgewater Medical or Clinical Care.
According to federal officials, many of the products sold and distributed by the above suppliers have not been approved by the FDA.
The agency warned doctors about buying drugs from sources other than licensed U.S. pharmacies. It is the fifth warning the agency has made this year about foreign suppliers providing unapproved drugs.
The FDA sent warning letters to more than 350 medical offices in the U.S., including some local doctors in Southern California.
The Associated Press contributed to this report.
fda, health, save money / consumer news
- NYC apartment explosion, collapse kills 2 18 min ago
- Gusty winds elevate fire dangers in SoCal
- Mountain lion roams Hollywood Hills - video
- India asked to join hunt for missing plane
- Tanker crash shuts I-5 North lanes in Castaic
- Compton teachers call in sick, want pay raise
- LA Co. focuses on stormwater capture projects
- Bizarre East LA bank robbery trial begins
- 5-alarm fire destroys San Francisco building
- Wild Colorado chase ends after 3 carjackings
- abcnews: Target thigh gap photo flap sparks outrage
- Elderly man fights off burglar with hammer
- Obama pushes health care on Funny or Die
- OTRC: Selena Gomez films Adidas ads (Photos)